Cross Border Impact Ventures
Women's and Children's Health Technology Fund

Cross Border Impact Ventures (CBIV) is a rare investment for Ceniarth in that it is an asset class, venture capital, where we do not traditionally invest, as well as a sector, healthcare, where we have done only a limited amount to date. That said, CBIV’s Women and Children Health Tech Fund was a very compelling gender-lens opportunity that convinced us to move outside our usual investment lanes.The fund makes Series A & B equity investments in healthcare companies in high-income countries with sophisticated healthcare industries, namely the United States, Israel, and Europe with a dual-impact strategy. The fund’s investments focus on both reducing inequality within those high-income markets, with a strong focus on intersectional gender analysis, as well as reducing inequality between high-income markets and low- and middle-income countries (LMICs). The latter goal is accomplished by developing a global access agreement with each portfolio company which could entail starting operations in LMICs, transferring technologies, or working with specific distributors.The fund has an ambitious impact target for the LMIC regions: 400,000 women's, children's and/or adolescents' lives saved and 8 million women's, children's and/or adolescents' lives improved over the life of the Fund. We made a $2M commitment to the senior Class A shares of the fund. The fund is a blended finance vehicle that benefits from a junior Class B tranche, as well as a guarantee facility from the Swedish development agency SIDA that further protects principal.